This is a unique combination of bitter plants that not only ‘reaches the target but acts too! Cell-line studies done in RCB, an ICMR institute for assessing Corona virus inhibiting activity of CoReach have shown encouraging results. Few case studies have shown an average of 98% decline in Corona virus count (viral load) in average just 3 days! We recommend Tab. CoReach in ongoing infection for early recuperation and for rapid relief from symptoms with non-compromised safety. Clinical trial conducted in Covid patients revealed results favorable to Tab. CoReach. Around 60% patients who repeated test were negative on day 6 of enrolment and who started with CoReach. No single case who received CoReach had progression of disease. All the patients receiving Tab. CoReach recovered early (2 days of early recovery). There were no drug side effects / adverse drug reactions noted. In summary, Tab. CoReach was proved to be safe and effective in managing mild to moderate Covid patients. More than 10,000 patients have trusted CoReach for getting better quickly. This has given us more confidence in serving to health of people.